Stryker Corporation (SYK) key performance indicators and operating metrics (5 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted operating income margin (non-GAAP) | 21.10 percent | FY2026-Q1 |
| Adjusted gross profit margin (non-GAAP) | 63.60 percent | FY2026-Q1 |
| Adjusted EPS (diluted, non-GAAP) | 2.60 USD_per_share | FY2026-Q1 |
| Reported net earnings | 745M | FY2026-Q1 |
| MedSurg and Neurotechnology organic sales growth | 12.60 percent | FY2025-Q4 |
Back to SYK overview · SYK earnings · SYK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.